FDA Just Redrew the Line for What Counts as a Medical Device — and a Lot of AI Health Products Just Landed on the Free Side
A blood glucose wearable can now be marketed as a general wellness product instead of a regulated medical device — the FDA's January 2026 guidance moves the line for AI health software further than most coverage let on.
- On May 24, 2026
- 0 Comment Read More
